Evaluation of the effects of 4 oral dosages of S 44121 versus placebo on cardiac function and NT-proBNP in patients with chronic heart failure and left ventricular dysfunction. A 12 week, randomized, double-blind, parallel group, placebo controlled, international multicentre study.

Trial Profile

Evaluation of the effects of 4 oral dosages of S 44121 versus placebo on cardiac function and NT-proBNP in patients with chronic heart failure and left ventricular dysfunction. A 12 week, randomized, double-blind, parallel group, placebo controlled, international multicentre study.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Apr 2013

At a glance

  • Drugs Aladorian (Primary)
  • Indications Chronic heart failure; Left ventricular dysfunction
  • Focus Pharmacodynamics
  • Most Recent Events

    • 23 Jun 2012 Actual end date (31 Mar 2011) added as reported by European Clinical Trials Database.
    • 23 Jun 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.
    • 14 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top